SLC2A5 and breast carcinoma: Jiang et al. [9] demonstrated that SLC2A5 can increase the risk of breast cancer development and metastasis by promoting fructose synthesis, which could induce lipoxygenase-12 and related fatty acid 12-HETE in breast cancer cells [9].